Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
Cotadutide and BAC Water Mix

Cotadutide Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example Cotadutide Titration Schedule

ParameterDetails
Phase 2b doses100 / 200 / 300 mcg once daily
Duration54 weeks (trial)

Discontinued April 2023 (strategic; the 400 mcg step in listed titration protocols is not documented in any trial). Notable for hepatic biomarker improvements no GLP-1 alone produced.

Possible vial strengths:

What Is It?

Cotadutide

GLP-1 / glucagon dual agonist.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix Cotadutide

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

Cotadutide Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

Cotadutide was designed as a dual GLP-1 and glucagon receptor agonist, not a GLP-1/GIP drug like tirzepatide. The GLP-1 side was aimed at glucose and appetite pathways, while the glucagon side was studied for effects on energy metabolism and liver-related markers.
MEDI0382 was the development code for cotadutide, so both names point to the same investigational peptide. A calculator page should include both terms because older clinical papers and trial records often use MEDI0382, while searchers may use cotadutide.
Cotadutide did not become an approved medicine and did not move into a full Phase 3 program. AstraZeneca discontinued development for strategic pipeline reasons, not because a new unexpected safety issue was identified.
Cotadutide attracted interest in NASH and metabolic liver research because the glucagon receptor component was linked to hepatic fat and liver biomarker effects. In a 54-week Phase 2b study, researchers tracked not only body weight and HbA1c, but also liver enzymes and fibrosis-related scoring tools.
For research math only, concentration equals peptide amount divided by final liquid volume. For example, if 3 mg of cotadutide research material were brought to a final volume of 6 mL, the concentration would be 0.5 mg/mL; a 150 mcg research amount would equal 0.30 mL, or 30 units on a U-100 scale. This is calculator math only, not a dosing guide.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides